Study of M5049 in Healthy Japanese and Caucasian Participants
Clinical trial NCT04880213 · COMPLETED
Trial details
- NCT number
- NCT04880213
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2021-11-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.